Scientists hunt for early warning signs of deadly tumors in genetic disorder
NCT ID NCT02211768
Summary
This study aimed to find better ways to spot when benign tumors turn cancerous in people with neurofibromatosis type 1 (NF1). Researchers tested a new type of scan (FLT-PET) and genetic analysis on tumor samples from a small group of participants. The goal was to learn if these tools could detect dangerous changes earlier than current methods to improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROFIBROMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.